Journal of neuro-oncology
A phase 2, open label, clinical trial of pre-surgical and adjuvant treatment of recurrent glioblastoma with tremelimumab and durvalumab alone and in combination.
Karan S Dixit, Priya Kumthekar, Rimas V Lukas, Andrew Williams, Matthew C Tate, James P Chandler, Pouya Jamshidi, Irene Helenowski, Hui Zhang, Orin Bloch, Jeffrey J Raizer
Published: 202610.1007/s11060-026-05446-1
No abstract available for this study.